You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Check point inhibitor

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Surgical Wound, Post Operative Pain Trial in Belgrade (Etoricoxib 90 Mg Oral Tablet, Dexamethasone 4mg)

Completed
  • Surgical Wound
  • Post Operative Pain
  • Etoricoxib 90 Mg Oral Tablet
  • Dexamethasone 4mg
  • Belgrade, Serbia
    School of Dental medicine, University of Belgrade
Mar 28, 2023

Pheochromocytoma, Metastatic, Pheochromocytoma Malignant, Paraganglioma, Malignant Trial in Beijing (Penpulimab)

Recruiting
  • Pheochromocytoma, Metastatic
  • +2 more
  • Beijing, China
    Peking Union Medical College Hospital
May 31, 2023

Responsiveness in Oncology Patients Based on Host Response

Recruiting
  • Non Small Cell Lung Cancer
  • Healthy
  • blood, stool and tissue samples collection
  • Dallas, Texas
    Baylor Scott and White Research Institute
Feb 9, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Radiofrequency ablation or microwave ablation)

Recruiting
  • Hepatocellular Carcinoma
  • Radiofrequency ablation or microwave ablation
  • Hong Kong, Hong Kong
    Chinese University of Hong Kong
Feb 27, 2022

Using Ex Vivo Tumoroids To Predict Immunotherapy Response In

Recruiting
  • Lung Cancer
  • +2 more
  • Standard of care immune checkpoint inhbitors
  • Fairway, Kansas
  • +1 more
Sep 19, 2022

Medical Oncology, Integrative Oncology, Medical Nutrition Therapy Trial in Buffalo (Diet)

Recruiting
  • Medical Oncology
  • +2 more
  • Diet
  • Buffalo, New York
    University at Buffalo / Great Lakes Cancer Care
Jul 25, 2022

Left Ventricular Assist Device Patients

Completed
  • End-stage Heart Failure
  • +2 more
  • VerifyNow antiplatelet therapy response test
  • Vienna, Austria
    Medical University of Vienna
Nov 28, 2023

Human Immunodeficiency Virus Type 1 Trial in Worldwide (D/C/F/TAF, Boosted Protease Inhibitor (bPI), FTC/TDF)

Completed
Has Results
  • Human Immunodeficiency Virus Type 1
  • Phoenix, Arizona
  • +81 more
Nov 25, 2021

Left Ventricular Hypertrophy, Hypertension Trial in Italy (ACE inhibitor Ramipril, non-RAS inhibitor antihypertensive therapy)

Completed
  • Left Ventricular Hypertrophy
  • Hypertension
  • ACE inhibitor Ramipril
  • non-RAS inhibitor antihypertensive therapy
  • Ponte San Pietro, Bergamo, Italy
  • +28 more
Jan 8, 2021

Primary and Metastatic Tumors in Renal Cell Carcinoma and

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • Immune checkpoint inhibitor targeting PD1
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jan 27, 2023

NSCLC Trial in Oslo (Atezolizumab, Radiotherapy)

Terminated
  • Non-small Cell Lung Cancer
  • Oslo, Norway
    Oslo University Hospital
Mar 25, 2021

Italy to Understand How Dose Check App Used With Xultophy®

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Catanzaro, Cz, Italy
  • +1 more
Oct 27, 2023

Saudi Arabia to Understand How Dose Check App Used With Tresiba

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Al Khobar, Saudi Arabia
  • +6 more
Nov 23, 2023

NSCLC Trial in Buderim, Adelaide (6-Thio-2'-Deoxyguanosine, Cemiplimab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Buderim, Queensland, Australia
  • +1 more
Jul 5, 2022

Unresectable Melanoma, Metastatic Melanoma, Stage III NSCLC Trial in Louisville, New York (IOV-4001)

Recruiting
  • Unresectable Melanoma
  • +3 more
  • IOV-4001
  • Louisville, Kentucky
  • +2 more
Nov 21, 2022

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

TDM for Optimized Outcome in Patients With mRCC.

Recruiting
  • Kidney Cancer
  • +4 more
  • Medical treatment for metastatic renal cell carcinoma
  • Århus C, Danmark, Denmark
  • +2 more
Dec 2, 2020

Papillary Renal Cell Carcinoma Type 2 Trial in France (Axitinib Oral Tablet [Inlyta], Pembrolizumab Injection [Keytruda])

Recruiting
  • Papillary Renal Cell Carcinoma Type 2
  • Axitinib Oral Tablet [Inlyta]
  • Pembrolizumab Injection [Keytruda]
  • Angers, France
  • +11 more
Aug 26, 2022

Solid Tumors Trial in Bruxelles, Wilrijk (BI 907828, Rifampicin)

Recruiting
  • Solid Tumors
  • Bruxelles, Belgium
  • +4 more
Jan 9, 2023

Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data

Recruiting
  • Breast Cancer
  • +4 more
  • anonymized data collection during programmed surveillance clinical follow up
  • Weston, Florida
    Cleveland Clinic Florida
Oct 27, 2022

Obesity, Maternal, Hypertension in Pregnancy, Hypertension, Pregnancy-Induced Trial in Pittsburgh (Family Check Up Heart, Family

Not yet recruiting
  • Obesity, Maternal
  • +4 more
  • Family Check Up Heart
  • Family Check-Up
  • Pittsburgh, Pennsylvania
  • +1 more
Jul 21, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Sarcoma, Soft Tissue Trial in Shanghai (Sintilimab, Doxorubicin Hydrochloride, Ifosfamide)

Recruiting
  • Sarcoma, Soft Tissue
  • Shanghai, Shanghai, China
    Fudan University, Cancer Hospital
Jul 13, 2020

Skin Health and Quality of Life in Patients Receiving

Not yet recruiting
  • Lung Cancer
  • +7 more
  • EQ-5D-5L questionnaire
  • +2 more
  • Roma, Italy
    Roberto Iacovelli
May 17, 2023

Cancer Of Prostate, Prostate Tumors Trial run by the National Cancer Institute (NCI) (ADT, Prednisone, M7824)

Recruiting
  • Cancer Of Prostate
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 6, 2022